KG Chemical Corporation (KRX:001390)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,790.00
-50.00 (-1.30%)
Oct 23, 2026, 3:30 PM KST

KG Chemical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9,773,4059,101,6478,863,1428,933,0576,607,3554,826,618
Revenue Growth
13.35%2.69%-0.78%35.20%36.89%30.93%
Gross Profit
1,069,8941,048,7551,024,1451,236,2131,088,502891,365
Operating Income
271,514300,981317,326442,249501,201446,153
Net Income
92,58369,65661,85695,763325,29474,404
Earnings Per Share
1377.071023.00918.581446.005012.541149.71
EPS Growth
51.18%11.37%-36.48%-71.15%335.98%72.23%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Steel and Porting
3,277,4703,193,4443,300,9823,429,8483,819,6893,354,789
Restaurant Industry
352,766341,429323,817368,153463,962325,839
Education
28,44328,72636,50240,12849,65362,343
Media and Broadcasting
72,79967,77081,52186,27079,10172,383
Financial Industry
11,83110,77912,2767,725--
Electronic Payment
995,063911,313979,273987,091893,550842,447
Automobile Manufacturing and Sales
4,775,9524,303,6373,905,0693,736,3691,019,606-
Real Estate Leasing
12,67312,77016,50314,32912,74612,663
Bio Business
120,377104,85489,10891,695125,26177,638
Chemistry
224,823216,526207,534223,731217,964176,434
Elimination of Internal Transactions
-98,792-89,600-89,442-52,282-74,178-97,920
Total
9,773,4059,101,6478,863,1428,933,0576,607,3554,826,618

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,065,204664,995907,945799,481493,289399,710
Total Debt
2,498,0921,890,4452,037,1411,812,6081,578,8571,880,546
Net Cash (Debt)
-1,432,888-1,225,450-1,129,196-1,013,127-1,085,568-1,480,836
Net Cash Growth
------
Net Cash Per Share
-21320.07-18005.88-16768.89-15298.19-16727.79-22882.20

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
159,753383,768377,484282,786277,814147,350
Capital Expenditures
-220,055-256,126-320,681-186,398-115,762-102,335
Free Cash Flow
-60,302127,64156,80396,387162,05345,015
Free Cash Flow Growth
-124.71%-41.07%-40.52%260.00%-78.52%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
10.95%11.52%11.55%13.84%16.47%18.47%
Operating Margin
2.78%3.31%3.58%4.95%7.59%9.24%
Pretax Margin
4.40%3.46%3.51%4.97%8.79%7.46%
Profit Margin
0.95%0.77%0.70%1.07%4.92%1.54%
FCF Margin
-0.62%1.40%0.64%1.08%2.45%0.93%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
150.000150.000130.000120.000100.000100.000
Dividend Per Share Growth
0%15.38%8.33%20.00%0%25.00%
Dividend Yield
3.96%2.85%3.54%1.75%2.43%1.63%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.755.084.064.900.875.70
P/FCF Ratio
-2.774.424.871.759.42
PS Ratio
0.030.040.030.050.040.09